My Intelligent Machines
MIMs participated in the American Association Cancer Research (AACR) last April 2022. We presented our E-poster on Augmented Intelligence to identify Drug Targets controlling metabolic reprogramming in Triple-Negative Breast Cancer (TNBC).
Contact us for more info: info@mims.ai
Register to our Newsletter to receive exciting scientific content: www.mims.ai
Source
interressant de voir les modèles utilisés dans différents domaines. Mes salutations de France ! Phil